Literature DB >> 15241729

Genetic dissection of corticosteroid receptor function in mice.

T M Wintermantel1, S Berger, E F Greiner, G Schütz.   

Abstract

Functional genomic technologies, including artificial chromosome-based transgenesis and conditional gene targeting, allowed us to generate mouse models harboring genes with loss-of-function mutations, gain-of-function mutations, spatially and/or temporally restricted mutations, tissue-specific mutations, and function-selective mutations. This kind of "allelic series" for corticosteroid receptors in mouse models provides a very useful resource for the molecular understanding of corticosteroid function in vivo. These models will also support the identification of steroid receptor target genes in order to define a steroid signaling cascade in molecular terms. They provide opportunities for the identification of compounds that regulate steroid receptors in a tissue-specific and function-selective manner. For example, selective glucocorticoid receptor modulators preventing receptor dimerization and DNA binding can be expected to reduce osteoporotic and/or diabetogenic side effects, but to display partial or full anti-inflammatory potential. Thus, these mouse models will help to evaluate distinct steroid receptor functions for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15241729     DOI: 10.1055/s-2004-814567

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  10 in total

1.  Pharmacogenetics of steroid-responsive acute graft-versus-host disease.

Authors:  Mukta Arora; Daniel J Weisdorf; Ryan M Shanley; Bharat Thyagarajan
Journal:  Clin Transplant       Date:  2017-04-04       Impact factor: 2.863

2.  Discovery of GW870086: a potent anti-inflammatory steroid with a unique pharmacological profile.

Authors:  I J Uings; D Needham; J Matthews; M Haase; R Austin; D Angell; K Leavens; J Holt; K Biggadike; S N Farrow
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

3.  Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease.

Authors:  Steve Bilodeau; Sophie Vallette-Kasic; Yves Gauthier; Dominique Figarella-Branger; Thierry Brue; France Berthelet; André Lacroix; Dalia Batista; Constantine Stratakis; Jeanette Hanson; Björn Meij; Jacques Drouin
Journal:  Genes Dev       Date:  2006-10-15       Impact factor: 11.361

4.  Glucocorticoid receptor regulates overlapping and differential gene subsets in developing and adult skin.

Authors:  Lisa M Sevilla; Pilar Bayo; Víctor Latorre; Ana Sanchis; Paloma Pérez
Journal:  Mol Endocrinol       Date:  2010-09-29

5.  SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX.

Authors:  Sam R Holmstrom; Sergey Chupreta; Alex Yick-Lun So; Jorge A Iñiguez-Lluhí
Journal:  Mol Endocrinol       Date:  2008-06-18

Review 6.  Glucocorticoid receptor physiology.

Authors:  Marjet D Heitzer; Irene M Wolf; Edwin R Sanchez; Selma F Witchel; Donald B DeFranco
Journal:  Rev Endocr Metab Disord       Date:  2007-12       Impact factor: 6.514

Review 7.  Nuclear receptors and AMPK: resetting metabolism.

Authors:  W Fan; M Downes; A Atkins; R Yu; R M Evans
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2012-03-12

8.  Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network.

Authors:  Angie L Bookout; Yangsik Jeong; Michael Downes; Ruth T Yu; Ronald M Evans; David J Mangelsdorf
Journal:  Cell       Date:  2006-08-25       Impact factor: 41.582

9.  Defective glucocorticoid receptor signaling and keratinocyte-autonomous defects contribute to skin phenotype of mouse embryos lacking the Hsp90 co-chaperone p23.

Authors:  Marta Madon-Simon; Iwona Grad; Pilar Bayo; Paloma Pérez; Didier Picard
Journal:  PLoS One       Date:  2017-06-26       Impact factor: 3.240

10.  A naturally hypersensitive glucocorticoid receptor elicits a compensatory reduction of hypothalamus-pituitary-adrenal axis activity early in ontogeny.

Authors:  Eduard Muráni; Siriluck Ponsuksili; Alexandra Jaeger; Andreas Görres; Armin Tuchscherer; Klaus Wimmers
Journal:  Open Biol       Date:  2016-07       Impact factor: 6.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.